Boyi Gan

29.4k total citations · 21 hit papers
107 papers, 17.4k citations indexed

About

Boyi Gan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Boyi Gan has authored 107 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 49 papers in Pulmonary and Respiratory Medicine and 46 papers in Cancer Research. Recurrent topics in Boyi Gan's work include Ferroptosis and cancer prognosis (45 papers), RNA modifications and cancer (42 papers) and Cancer, Lipids, and Metabolism (22 papers). Boyi Gan is often cited by papers focused on Ferroptosis and cancer prognosis (45 papers), RNA modifications and cancer (42 papers) and Cancer, Lipids, and Metabolism (22 papers). Boyi Gan collaborates with scholars based in United States, China and Japan. Boyi Gan's co-authors include Pranavi Koppula, Li Zhuang, Guang Lei, Yilei Zhang, Li Zhuang, Xiaoguang Liu, Hyemin Lee, Chao Mao, Yuelong Yan and Kellen Olszewski and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Boyi Gan

102 papers receiving 17.3k citations

Hit Papers

Cystine transporter SLC7A11/xCT in cancer: ferr... 2015 2026 2018 2022 2020 2022 2021 2020 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
    2020 1.7k citations Pranavi Koppula, Li Zhuang et al. profile →
  2. Targeting ferroptosis as a vulnerability in cancer
    2022 1.6k citations Guang Lei, Li Zhuang et al. profile →
  3. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
    2021 1.3k citations Chao Mao, Xiaoguang Liu et al. profile →
  4. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
    2020 940 citations Guang Lei, Yilei Zhang et al. profile →
  5. Energy-stress-mediated AMPK activation inhibits ferroptosis
    2020 851 citations Hyemin Lee, Fereshteh Zandkarimi et al. Nature Cell Biology profile →
  6. BAP1 links metabolic regulation of ferroptosis to tumour suppression
    2018 743 citations Yilei Zhang, Jiejun Shi et al. Nature Cell Biology profile →
  7. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer
    2018 665 citations Pranavi Koppula, Yilei Zhang et al. Cancer Communications profile →
  8. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis
    2023 648 citations Xiaoguang Liu, Litong Nie et al. Nature Cell Biology profile →
  9. Long noncoding RNA MALAT1 suppresses breast cancer metastasis
    2018 546 citations Jongchan Kim, Hai-long Piao et al. Nature Genetics profile →
  10. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
    2021 533 citations Yilei Zhang, Litong Nie et al. Nature Communications profile →
  11. AMPK modulates Hippo pathway activity to regulate energy homeostasis
    2015 433 citations Wenqi Wang, Zhen‐Dong Xiao et al. Nature Cell Biology profile →
  12. Mitochondrial regulation of ferroptosis
    2021 397 citations Boyi Gan The Journal of Cell Biology profile →
  13. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer
    2020 370 citations Xiaoguang Liu, Kellen Olszewski et al. Nature Cell Biology profile →
  14. Ferroptosis, radiotherapy, and combination therapeutic strategies
    2021 351 citations Guang Lei, Chao Mao et al. profile →
  15. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers
    2022 323 citations Pranavi Koppula, Guang Lei et al. Nature Communications profile →
  16. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
    2024 249 citations Guang Lei, Li Zhuang et al. Cancer Cell profile →
  17. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells
    2023 176 citations Yuelong Yan, Hongqi Teng et al. Nature Communications profile →
  18. Disulfidptosis: disulfide stress–induced cell death
    2023 143 citations Xiaoguang Liu, Li Zhuang et al. profile →
  19. Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond
    2024 91 citations Chao Mao, Li Zhuang et al. profile →
  20. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer
    2024 69 citations Guoshu Bi, Jiaqi Liang et al. Nature Communications profile →
  21. Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance
    2024 65 citations Hyemin Lee, Amber D. Horbath et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyi Gan United States 56 11.9k 8.9k 8.3k 1.8k 1.6k 107 17.4k
Caroline E. Gleason United States 6 9.0k 0.8× 8.8k 1.0× 6.3k 0.8× 1.6k 0.8× 890 0.5× 6 14.8k
Andras J. Bauer United States 8 8.7k 0.7× 8.5k 1.0× 6.0k 0.7× 1.4k 0.8× 829 0.5× 9 14.2k
Kathryn M. Lemberg United States 7 7.9k 0.7× 7.6k 0.9× 5.5k 0.7× 1.3k 0.7× 779 0.5× 18 13.2k
Alexandra M. Cantley United States 7 7.8k 0.7× 7.6k 0.9× 5.3k 0.6× 1.3k 0.7× 767 0.5× 7 13.0k
Alec C. Kimmelman United States 56 12.3k 1.0× 2.5k 0.3× 6.6k 0.8× 6.1k 3.3× 5.2k 3.2× 93 20.1k
Agnieszka K. Witkiewicz United States 60 7.0k 0.6× 3.1k 0.3× 5.1k 0.6× 6.5k 3.6× 1.3k 0.8× 176 13.6k
Dean G. Tang United States 66 8.6k 0.7× 2.5k 0.3× 4.5k 0.5× 5.3k 2.9× 470 0.3× 172 14.4k
James A. Olzmann United States 40 7.5k 0.6× 3.4k 0.4× 2.9k 0.3× 773 0.4× 1.7k 1.0× 71 12.3k
Li Zhuang China 35 5.5k 0.5× 5.1k 0.6× 3.9k 0.5× 1.4k 0.8× 568 0.3× 101 9.0k
Paola Chiarugi Italy 67 9.4k 0.8× 1.5k 0.2× 4.7k 0.6× 4.1k 2.2× 903 0.6× 186 15.5k

Countries citing papers authored by Boyi Gan

Since Specialization
Citations

This map shows the geographic impact of Boyi Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyi Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyi Gan more than expected).

Fields of papers citing papers by Boyi Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyi Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyi Gan. The network helps show where Boyi Gan may publish in the future.

Co-authorship network of co-authors of Boyi Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Boyi Gan. A scholar is included among the top collaborators of Boyi Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyi Gan. Boyi Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Guoshu, Jiaqi Liang, Yunyi Bian, et al.. (2025). Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC. Nature Communications. 16(1). 8181–8181. 1 indexed citations
2.
Meng, Chenling, Kevin Lin, Wei Shi, et al.. (2025). Histone methyltransferase ASH1L primes metastases and metabolic reprogramming of macrophages in the bone niche. Nature Communications. 16(1). 4681–4681. 3 indexed citations
3.
Arama, Eli, Katia Cosentino, Peter E. Czabotar, et al.. (2025). Towards a molecular and structural definition of cell death. Nature Structural & Molecular Biology. 32(10). 1854–1858.
4.
Conradt, Barbara, Edward A. Miao, Junying Yuan, et al.. (2024). The story behind the emergence of different forms of cell death. Developmental Cell. 59(19). 2519–2522. 1 indexed citations
5.
Jiang, Dadi, Youming Guo, Tianyu Wang, et al.. (2024). IRE1α determines ferroptosis sensitivity through regulation of glutathione synthesis. Nature Communications. 15(1). 4114–4114. 22 indexed citations
6.
Bi, Guoshu, Jiaqi Liang, Guangyao Shan, et al.. (2023). Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells. Cancer Research. 83(14). 2387–2404. 37 indexed citations
7.
Li, Qidong & Boyi Gan. (2023). Uncovering the IL‐1β‐PCAF‐NNT axis: A new player in ferroptosis and tumor immune evasion. Cancer Communications. 43(9). 1048–1050. 4 indexed citations
8.
Wang, Zuli, Lianlian Ouyang, Tiansheng Li, et al.. (2023). The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Oncogene. 42(36). 2688–2700. 22 indexed citations
9.
Yan, Yuelong, Hongqi Teng, Qinglei Hang, et al.. (2023). SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nature Communications. 14(1). 3673–3673. 176 indexed citations breakdown →
10.
Nie, Litong, Chao Wang, Xiaoguang Liu, et al.. (2023). DePARylation is critical for S phase progression and cell survival. eLife. 12. 9 indexed citations
11.
Huang, Shan, et al.. (2023). The deubiquitinase ZRANB1 is an E3 ubiquitin ligase for SLC7A11 and regulates ferroptotic resistance. The Journal of Cell Biology. 222(11). 15 indexed citations
12.
Zhang, Yilei, Jiejun Shi, Xiaoguang Liu, et al.. (2020). H2A Monoubiquitination Links Glucose Availability to Epigenetic Regulation of the Endoplasmic Reticulum Stress Response and Cancer Cell Death. Cancer Research. 80(11). 2243–2256. 31 indexed citations
13.
Lee, Hyemin, Fereshteh Zandkarimi, Yilei Zhang, et al.. (2020). Energy-stress-mediated AMPK activation inhibits ferroptosis. Nature Cell Biology. 22(2). 225–234. 851 indexed citations breakdown →
14.
Kim, Jongchan, Hai-long Piao, Beom‐Jun Kim, et al.. (2018). Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nature Genetics. 50(12). 1705–1715. 546 indexed citations breakdown →
15.
Xiao, Zhen‐Dong, Leng Han, Hyemin Lee, et al.. (2017). Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nature Communications. 8(1). 783–783. 170 indexed citations
16.
Kim, Jongchan, Ashley N. Siverly, Dahu Chen, et al.. (2016). Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Cancer Research. 76(21). 6424–6435. 78 indexed citations
17.
Liu, Xiaowen, Zhen‐Dong Xiao, Leng Han, et al.. (2016). LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nature Cell Biology. 18(4). 431–442. 247 indexed citations
18.
Lin, Aifu, Hai-long Piao, Zhuang Li, et al.. (2014). FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway. Cancer Research. 74(6). 1682–1693. 108 indexed citations
19.
Gan, Boyi, Carol S. Lim, Gerald Chu, et al.. (2010). FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis. Cancer Cell. 18(5). 472–484. 116 indexed citations
20.
Gan, Boyi, Zara Melkoumian, Xiaoyang Wu, Kun‐Liang Guan, & Jun‐Lin Guan. (2005). Identification of FIP200 interaction with the TSC1–TSC2 complex and its role in regulation of cell size control. The Journal of Cell Biology. 170(3). 379–389. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline E. Gleason Breakdown of academic impact, for papers by Andras J. Bauer Breakdown of academic impact, for papers by Kathryn M. Lemberg Breakdown of academic impact, for papers by Alexandra M. Cantley Breakdown of academic impact, for papers by Alec C. Kimmelman Breakdown of academic impact, for papers by Agnieszka K. Witkiewicz Breakdown of academic impact, for papers by Dean G. Tang Breakdown of academic impact, for papers by James A. Olzmann Breakdown of academic impact, for papers by Li Zhuang Breakdown of academic impact, for papers by Paola Chiarugi
Rankless by CCL
2026